Reported Jul 15, 2026 · Ongoing
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for:…
Reliance Life Sciences Private Limited
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Reliance Life Sciences Private Limited · Ttc Area Of Midc · Navi Mumbai, N/A · N/A
Is this the product you have?
Bortezomib for Injection 3.5mg/Vial10 mL per Single-Dose VialFor Intravenous or Subcutaneous Use
- Manufactured forSomerset Therapeutics, LLC., Somerset, NJ 08873
- NDC70069-0836-01
- Lot codes and dates
- Lot
- expiry
RBIH0125A Jan 312028RBIH0225A Feb 292028RBIH0325A Feb 292028RBIH0525A Mar 312028
- Amount recalled
- 11,400 vials
This recall covers 4 products
The agency filed one notice per product. You are reading one of them; the other 3 are below.
Where it was sold
- Nationwide
Why it was recalled
Lack of Sterility Assurance
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Reliance Life Sciences Private Limited recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.